NDC 33261-922

Butalbital, Aspirin, and Caffeine

Butalbital, Aspirin, And Caffeine

Butalbital, Aspirin, and Caffeine is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Aidarex Pharmaceuticals Llc. The primary component is Butalbital; Aspirin; Caffeine.

Product ID33261-922_208b6d91-6e3f-48ac-a86d-767e735dadb8
NDC33261-922
Product TypeHuman Prescription Drug
Proprietary NameButalbital, Aspirin, and Caffeine
Generic NameButalbital, Aspirin, And Caffeine
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date1976-05-04
Marketing CategoryNDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC
Application NumberNDA017534
Labeler NameAidarex Pharmaceuticals LLC
Substance NameBUTALBITAL; ASPIRIN; CAFFEINE
Active Ingredient Strength50 mg/1; mg/1; mg/1
Pharm ClassesBarbiturates [CS],Barbiturate [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE]
DEA ScheduleCIII
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 33261-922-30

30 CAPSULE in 1 BOTTLE, PLASTIC (33261-922-30)
Marketing Start Date1976-05-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 33261-922-30 [33261092230]

Butalbital, Aspirin, and Caffeine CAPSULE
Marketing CategoryNDA AUTHORIZED GENERIC
Application NumberNDA017534
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1976-05-04
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
BUTALBITAL50 mg/1

OpenFDA Data

SPL SET ID:166e131d-9c1a-461f-bf33-e45d4ec36ff2
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 238134
    • Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
    • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
    • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722

    • Pharmacological Class

    • Barbiturates [CS]
    • Barbiturate [EPC]
    • Cyclooxygenase Inhibitors [MoA]
    • Decreased Prostaglandin Production [PE]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]
    • Platelet Aggregation Inhibitor [EPC]
    • Decreased Platelet Aggregation [PE]
    • Central Nervous System Stimulant [EPC]
    • Methylxanthine [EPC]
    • Xanthines [CS]
    • Central Nervous System Stimulation [PE]
    • Anti-Inflammatory Agents
    • Non-Steroidal [CS]

    NDC Crossover Matching brand name "Butalbital, Aspirin, and Caffeine" or generic name "Butalbital, Aspirin, And Caffeine"

    NDCBrand NameGeneric Name
    0527-1552Butalbital, aspirin, and caffeineButalbital, aspirin, and caffeine
    0591-3219Butalbital, Aspirin, and Caffeinebutalbital, aspirin, and caffeine
    21695-139Butalbital, Aspirin, and Caffeinebutalbital, aspirin, and caffeine
    29033-215Butalbital, Aspirin, and CaffeineButalbital, Aspirin, and Caffeine
    33261-922Butalbital, Aspirin, and Caffeinebutalbital, aspirin, and caffeine
    50090-1580Butalbital, aspirin, and caffeineButalbital, aspirin, and caffeine
    55700-129Butalbital, aspirin, and caffeineButalbital, aspirin, and caffeine
    62135-433butalbital, aspirin, and caffeinebutalbital, aspirin, and caffeine
    79739-7192Butalbital, Aspirin, and CaffeineButalbital, Aspirin, and Caffeine
    0023-6146FiorinalButalbital, Aspirin, and Caffeine
    52544-955FiorinalButalbital, Aspirin, and Caffeine
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.